These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35176116)

  • 21. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
    Young GP; Woodman RJ; Symonds E
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
    Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
    Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of an online, validated family history questionnaire to the Dutch FIT-based screening programme did not improve its diagnostic yield.
    Roos VH; Kallenberg FGJ; van der Vlugt M; Bongers EJC; Aalfs CM; Bossuyt PMM; Dekker E
    Br J Cancer; 2020 Jun; 122(12):1865-1871. PubMed ID: 32307443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests.
    de Klerk CM; Wieten E; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MCW; Dekker E
    Am J Gastroenterol; 2019 Mar; 114(3):511-518. PubMed ID: 30789417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
    von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
    Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests.
    Symonds EL; Pedersen S; Cole SR; Massolino J; Byrne D; Guy J; Backhouse P; Fraser RJ; LaPointe L; Young GP
    Asian Pac J Cancer Prev; 2015; 16(18):8455-60. PubMed ID: 26745101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.
    Kapidzic A; van Roon AH; van Leerdam ME; van Vuuren AJ; van Ballegooijen M; Lansdorp-Vogelaar I; Spijker W; Izelaar K; Hol L; Kuipers EJ
    Gut; 2017 Jan; 66(1):118-123. PubMed ID: 26370109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield.
    Bonander C; Westerberg M; Chauca Strand G; Forsberg A; Strömberg U
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38830030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.
    Nielson CM; Petrik AF; Jacob L; Vollmer WM; Keast EM; Schneider JL; Rivelli JS; Kapka TJ; Meenan RT; Mummadi RR; Green BB; Coronado GD
    Cancer Med; 2018 Sep; 7(9):4781-4790. PubMed ID: 30101513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme.
    Clark G; Strachan JA; Carey FA; Godfrey T; Irvine A; McPherson A; Brand J; Anderson AS; Fraser CG; Steele RJ
    Gut; 2021 Jan; 70(1):106-113. PubMed ID: 32234803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme.
    Hol L; Kuipers EJ; van Ballegooijen M; van Vuuren AJ; Reijerink JC; Habbema DJ; van Leerdam ME
    Int J Cancer; 2012 May; 130(9):2096-102. PubMed ID: 21702046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
    Passamonti B; Malaspina M; Fraser CG; Tintori B; Carlani A; D'Angelo V; Galeazzi P; Di Dato E; Mariotti L; Bulletti S; D'Amico MR; Gustinucci D; Martinelli N; Spita N; Cesarini E; Rubeca T; Giaimo M; Segnan N; Senore C
    Gut; 2018 Mar; 67(3):485-496. PubMed ID: 27974550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.
    van der Vlugt M; Grobbee EJ; Bossuyt PM; Bos ACRK; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1237-1243.e2. PubMed ID: 29427732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland.
    Sarkeala T; Färkkilä M; Anttila A; Hyöty M; Kairaluoma M; Rautio T; Voutilainen M; Helander S; Jäntti M; Lehtinen M; Patrikka L; Malila N; Heinävaara S
    BMJ Open; 2021 Feb; 11(2):e046667. PubMed ID: 33558363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mundt MW; Spijker WJ; Bongers EJC; Kuipers EJ; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
    Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
    Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.